Michael Cleary

Pathology / Anatomic Pathology

Credentials: · · ·

History

Pathology
Brigham and Women's Hospital
1981–1985
School of Natural Sciences, University of California, Merced, CA
University of Cincinnati College of Medicine
1977–1981

Research

The menin tumor suppressor protein is an essential oncogenic cofactor for MLL-associated leukemogenesis
Cell · 2005 · Last of 6 authors · 576 citations
Glycogen synthase kinase 3 in MLL leukaemia maintenance and targeted therapy
Nature · 2008 · Last of 6 authors · 235 citations
The miR-17-92 microRNA polycistron regulates MLL leukemia stem cell potential by modulating p21 expression
Cancer Research · 2010 · Last of 8 authors · 151 citations

MW
Michael Wei
6 papers
Matthew Porteus
4 papers · 2 as a resident
Erin Breese
3 papers · 2 as a fellow
Michaela Liedtke
3 papers
Alix Seif
2 papers
James Zehnder
2 papers
Jason Kurzer
2 papers
Ravi Majeti
2 papers
Catherine Dawson-Gore
1 paper
CC
Ching-Pin Chang
1 paper
Kathleen Sakamoto
1 paper
Marcin Wlodarski
1 paper

Grants

Functional and Translational Epigenomics of Acute Lymphoblastic Leukemia
National Cancer Institute · R01
Contact PI · $1.8M · Stanford University
2018–2024
Epigenetic Mechanisms and Targeting in MLL Leukemia
National Cancer Institute · R01
Contact PI · $4.7M · Stanford University
2005–2022
Stanford Cancer Institute
National Cancer Institute · P30
Project lead · $481.3K · Stanford University
2007–2022
Role of PGDH in Leukemia Pathogenesis
National Cancer Institute · R01
Contact PI · $1.6M · Stanford University
2012–2017